A DPYD Variant (Y186C) in Individuals of African Ancestry Is Associated With Reduced DPD Enzyme Activity

Overview of attention for article published in Clinical Pharmacology & Therapeutics, April 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 12 news outlets
blogs: 1 blog

twitter: 1 X user
guideline: 1 clinical guideline source

Readers on

mendeley: 95 Mendeley

So far, Altmetric has seen 2 Guidelines that reference this research output.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update

Clinical guideline published by Clinical Pharmacogenetics Implementation Consortium (CPIC) on 20 Nov 2017

The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an international group dedicated to enhancing the use of pharmacogenetic testing in clinical settings. They develop and share peer-reviewed, evidence-based guidelines to aid healthcare providers in making informed prescribing decisions based on genetic test results.

Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing

Clinical guideline published by Clinical Pharmacogenetics Implementation Consortium (CPIC) on 29 Aug 2013

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.